Russia has announced the development of its own mRNA-based cancer vaccine, which is expected to be available for free to patients from early 2025. The vaccine has shown promising results in pre-clinical trials, suppressing tumor development and potential metastases.
According to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, the vaccine's development was a collaborative effort between several teams of scientists from renowned research institutions. The research was conducted in accordance with international standards and regulations.
We have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation. I hope that soon they will be effectively used as methods of individual therapy.Russian Vaccine Chief
Russian Health Minister Mikhail Murashko stated that the research was financed by the state as part of a governmental order. They emphasized that the development of the vaccine is a result of the collaborative efforts of Russian scientists and researchers. The exact details of the vaccine's distribution and administration are yet to be announced.
The vaccine's distribution will be free of charge, with Russia planning to provide no-cost treatment for terminally ill patients. Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg mentioned the potential for personalized cancer vaccines, which could be made possible using artificial neural networks.
Role of vaccine in cancer management:
The vaccine's availability is expected to start in early 2025. Therapeutic cancer vaccines work by directing the immune system to recognize specific proteins or antigens produced by tumor cells, enabling it to launch a targeted attack. Some vaccines utilize weakened or modified viruses to deliver these antigens, triggering a robust immune response. In contrast, preventive vaccines, such as the HPV vaccine, safeguard against viruses that can lead to cancer, thereby reducing the risk of certain cancers, like cervical cancer. By bolstering the body's innate defenses, vaccines can impede tumor growth, prevent relapse, or even eradicate early-stage cancers, offering a valuable tool in the fight against cancer.
(Input From Various Sources)
(Rehash/Neha Kamble/MSM)